Hernandezine induces autophagic cell death in hepatocellular carcinoma cells via the AMPK/mTOR signaling pathway

doi:10.16139/j.1007-9610.2025.02.08

Abstract

Abstract:

Objective To investigate the autophagy activation effect of hernandezine (HER) on hepatocellular carcinoma (HCC) cells and its role in inducing autophagic cell death. Methods The inhibitory effects of HER on the proliferation of HCC cell lines Hep 3B and Huh-7 were assessed using CCK-8 assay. HCC cells were treated with HER at different concentrations and time points gradient. Western blot analysis was performed to evaluate the conversion of autophagy marker LC3 from type Ⅰ to type Ⅱ and the levels of SQSTM1/p62. Stable red fluorescent protein(RFP)-LC3-expressing cell lines were established through lentiviral infection, and the accumulation of RFP-LC3 puncta following HER treatment was observed under confocal microscope. Autophagosomes in HER-treated cells were visualized using transmission electron microscopy. The effects of autophagy inhibitors, bafilomycin A1 (BafA1) or hydroxychloroquine (HCQ), in combination with HER were investigated by analyzing cell death rates via flow cytometry. The phosphorylation levels of adenosine 5′-monophosphate(AMP)-activated protein kinase(AMPK) and mammalian target of rapamycin(mTOR) were assessed by Western blot.Results HER inhibited the proliferation of HCC cells Hep 3B and Huh-7, promoted the conversion of LC3-Ⅰ to LC3-Ⅱ, and activated autophagy in a dose- and time-dependent manner. Confocal microscopy and transmission electron microscopy revealed a significant increase in autophagic vesicles in HER-treated cells. HER-induced cell death was attenuated by the autophagy inhibitors BafA1 or HCQ. HER treatment increased AMPK phosphorylation levels while decreasing mTOR phosphorylation levels.Conclusions HER induces autophagy and promotes autophagic cell death in HCC cells via the AMPK/mTOR signaling pathway.

Key words: Hepatocellular carcinoma(HCC), Hernandezine(HER), Adenosine 5'-monophosphate(AMP)-activated protein kinase(AMPK)/mammalian target of rapamycin(mTOR), Autophagic cell death

CLC Number:

R735.7

WANG Jun, HU Gangfeng, GAO Weichen, WANG Lubing. Hernandezine induces autophagic cell death in hepatocellular carcinoma cells via the AMPK/mTOR signaling pathway[J]. Journal of Surgery Concepts & Practice, 2025, 30(2): 138-145.

Figures/Tables 6

Fig 1

Fig 2

Fig 3

Fig 4

Fig 5

Fig 6

References 26

[1]	中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J]. 中国实用外科杂志, 2024, 44(4):361-386.
	Bureau of Medical Administration, National Health Commission of the People's Republic of China. Guideline for diagnosis and treatment of hepatocellular carcinoma(2024 edition)[J]. Chin J Pract Surg, 2024, 44(4):361-386.
[2]	缪伟刚, 周金意, 韩仁强. 全球肝癌流行数据解析[J]. 中华流行病学杂志, 2024, 45(6):865-869.
	MIAO W G, ZHOU J Y, HAN R Q. Analysis of global liver cancer statistics[J]. Chin J Epidemiol, 2024, 45(6):865-869.
[3]	郝运, 李川, 文天夫, 等. 全球及中国的肝癌流行病学特征: 基于《2022全球癌症统计报告》解读[J]. 中国普外基础与临床杂志, 2024, 31(7):781-789.
	HAO Y, LI C, WEN T F, et al. Epidemiological characteristics of liver cancer worldwide and in China: an interpretation of global cancer statistics 2022[J]. Chin J Bases Clin Gen Surg, 2024, 31(7):781-789.
[4]	SIEGEL R L, GIAQUINTO A N, JEMAL A. Cancer statistics,2024[J]. CA Cancer J Clin, 2024, 74(1):12-49.
[5]	BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424.
[6]	LI P, LI X, WU Y, et al. A novel AMPK activator hernandezine inhibits LPS-induced TNFα production[J]. Oncotarget, 2017, 8(40):67218-67226. doi: 10.18632/oncotarget.18365 pmid: 28978028
[7]	LAW B Y, MOK S W, CHAN W K, et al. Hernandezine, a novel AMPK activator induces autophagic cell death in drug-resistant cancers[J]. Oncotarget, 2016, 7(7):8090-8104. doi: 10.18632/oncotarget.6980 pmid: 26811496
[8]	WANG X, LI X, XIA Y, et al. Hernandezine regulates proliferation and autophagy-induced apoptosis in melanoma cells[J]. J Nat Prod, 2022, 85(5):1351-1362. doi: 10.1021/acs.jnatprod.2c00098 pmid: 35544345
[9]	HSIAO S H, LU Y J, YANG C C, et al. Hernandezine, a bisbenzylisoquinoline alkaloid with selective inhibitory activity against multidrug-resistance-linked ATP-binding cassette drug transporter ABCB1[J]. J Nat Prod, 2016, 79(8):2135-2142.
[10]	Kuok C, Wang Q, Fong P, et al. Inhibitory effect of hernandezine on the proliferation of hepatocellular carcinoma[J]. Biol Pharm Bull, 2023, 46(2):245-256. doi: 10.1248/bpb.b22-00612 pmid: 36724952
[11]	KLIONSKY D J, ABDEL-AZIZ A K, ABDELFATAH S, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹[J]. Autophagy, 2021, 17(1):1-382. doi: 10.1080/15548627.2020.1797280 pmid: 33634751
[12]	LAHIRI V, HAWKINS W D, KLIONSKY D J. Watch what you (self-) eat: autophagic mechanisms that modulate metabolism[J]. Cell Metab, 2019, 29(4):803-826. doi: S1550-4131(19)30131-7 pmid: 30943392
[13]	LI J, CHEN X, KANG R, et al. Regulation and function of autophagy in pancreatic cancer[J]. Autophagy, 2021, 17(11):3275-3296.
[14]	GALLUZZI L, GREEN D R. Autophagy-independent functions of the autophagy machinery[J]. Cell, 2019, 177(7):1682-1699. doi: S0092-8674(19)30554-9 pmid: 31199916
[15]	DENTON D, KUMAR S. Autophagy-dependent cell death[J]. Cell Death Differ, 2019, 26(4):605-616. doi: 10.1038/s41418-018-0252-y pmid: 30568239
[16]	CHEN X, SHI C, HE M, et al. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets[J]. Signal Transduct Target Ther, 2023, 8(1):352.
[17]	FENG Q, SUN L, SUALEH M J, et al. Hernandezine promotes cancer cell apoptosis and disrupts the lysosomal acidic environment and cathepsin D maturation[J]. Chin J Nat Med, 2024, 22(5):387-401.
[18]	BAI J, ZHANG S, CAO J, et al. Hernandezine, a natural herbal alkaloid, ameliorates type 2 diabetes by activating AMPK in two mouse models[J]. Phytomedicine,2022, 105:154366
[19]	SONG C F, HU Y H, MANG Z G, et al. Hernandezine induces autophagic cell death in human pancreatic cancer cells via activation of the ROS/AMPK signaling pathway[J]. Acta Pharmacol Sin, 2023, 44(4):865-876.
[20]	MIHAYLOVA M M, SHAW R J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism[J]. Nat Cell Biol, 2011, 13(9):1016-1023. doi: 10.1038/ncb2329 pmid: 21892142
[21]	HERZIG S, SHAW R J. AMPK: guardian of metabolism and mitochondrial homeostasis[J]. Nat Rev Mol Cell Biol, 2018, 19(2):121-135.
[22]	SONG C, XU W, WU H, et al. Photodynamic therapy induces autophagy-mediated cell death in human colorectal cancer cells via activation of the ROS/JNK signaling pathway[J]. Cell Death Dis, 2020, 11(10):938.
[23]	LING NXY, KACZMAREK A, HOQUE A, et al. mTORC1 directly inhibits AMPK to promote cell proli-feation under nutrient stress[J]. Nat Metab, 2020, 2(1):41-49.
[24]	PARK J M, LEE D H, KIM D H. Redefining the role of AMPK in autophagy and the energy stress response[J]. Nat Commun, 2023, 14(1):2994.
[25]	KIM J, GUAN K L. mTOR as a central hub of nutrient signalling and cell growth[J]. Nat Cell Biol, 2019, 21(1):63-71. doi: 10.1038/s41556-018-0205-1 pmid: 30602761
[26]	MOSSMANN D, PARK S, HALL M N. mTOR signalling and cellular metabolism are mutual determinants in cancer[J]. Nat Rev Cancer, 2018, 18(12):744-757. doi: 10.1038/s41568-018-0074-8 pmid: 30425336